Regulation of G2/M events by Cdc25A through phosphorylation-dependent modulation of its stability

EMBO Journal

Volumn 21, Issue 21, 2002, Pages 5911-5920

  Mailand, Niels ^a   Podtelejnikov, Alexandre V ^a   Groth, Anja ^a   Mann, Matthias ^a   Bartek, Jiri ^a   Lukas, Jiri ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

Cdc25A phosphatase; G2 checkpoint; Mitosis; Phosphorylation; Protein degradation

Indexed keywords

CELL DNA; CYCLIN B; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; PROTEASOME; PROTEIN TYROSINE PHOSPHATASE; RNA; UBIQUITIN;

ARTICLE; CELL CYCLE G2 PHASE; CELL DIVISION; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; ENZYME ACTIVATION; GENOTOXICITY; HUMAN; HUMAN CELL; MITOSIS INHIBITION; MITOSIS RATE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; RNA REPLICATION; STRESS;

AMINO ACID SEQUENCE; ANIMALS; CDC2 PROTEIN KINASE; CDC25 PHOSPHATASE; CYCLIN B; DNA DAMAGE; ENZYME STABILITY; G2 PHASE; HUMANS; MITOSIS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; SERINE; UBIQUITIN;

EUKARYOTA;

EID: 0036847320     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/cdf567     Document Type: Article

References (60)

1. Abraham, R.T. (2001) Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev., 15, 2177-2196.
2. cdc2 regulation. Mol. Cell. Biol., 13, 1675-1685.
3. Baldin, V., Cans, C., Knibiehler, M. and Ducommun, B. (1997) Phosphorylation of human CDC25B phosphatase by CDK1-cyclin A triggers its proteasome-dependent degradation. J. Biol. Chem., 272, 32731-32734.
4. Bernardi, R., Liebermann, D.A. and Hoffman, B. (2000) Cdc25A stability is controlled by the ubiquitin-proteasome pathway during cell cycle progression and terminal differentiation. Oncogene, 19, 2447-2454.
5. Blasina, A., Price, B.D., Turenne, G.A. and McGowan, C.H. (1999) Caffeine inhibits the checkpoint kinase ATM. Curr. Biol., 9, 1135-1138.
6. 1/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases. Mol. Cell. Biol., 19, 6183-6194.
7. Booher, R.N., Holman, P.S. and Fattaey, A. (1997) Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity. J. Biol. Chem., 272, 22300-22306.
8. 2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature, 411, 102-107.
9. Cangi, M.G., Cukor, B., Soung, P., Signoretti, S., Moreira, G., Jr, Ranashinge, M., Cady, B., Pagano, M. and Loda, M. (2000) Role of the Cdc25A phosphatase in human breast cancer. J. Clin. Invest., 106, 753-761.
10. Chen, M.S., Hurov, J., White, L.S., Woodford-Thomas, T. and Piwnica-Worms, H. (2001) Absence of apparent phenotype in mice lacking Cdc25C protein phosphatase. Mol. Cell. Biol., 21, 3853-3861.
11. Clute, P. and Pines, J. (1999) Temporal and spatial control of cyclin B1 destruction in metaphase. Nat. Cell Biol., 1, 82-87.
12. 2/M are overexpressed in aneuploid mammary carcinomas. Cytometry, 42, 254-260.
13. Costanzo, V., Robertson, K., Ying, C.Y., Kim, E., Avvedimento, E., Gottesman, M., Grieco, D. and Gautier, J. (2000) Reconstitution of an ATM-dependent checkpoint that inhibits chromosomal DNA replication following DNA damage. Mol. Cell, 6, 649-659.
14. den Elzen, N. and Pines, J. (2001) Cyclin A is destroyed in prometaphase and can delay chromosome alignment and anaphase. J. Cell Biol., 153, 121-136.
15. Falck, J., Mailand, N., Syljuasen, R.G., Bartek, J. and Lukas, J. (2001) The ATM-Chk2-Cdc25A checkpoint pathway guards against radio-resistant DNA synthesis. Nature, 410, 842-847.
16. Galaktionov, K. and Beach, D. (1991) Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: Evidence for multiple roles of mitotic cyclins. Cell, 67, 1181-1194.
17. Galaktionov, K., Lee, A.K., Eckstein, J., Draetta, G., Meckler, J., Loda, M. and Beach, D. (1995) CDC25 phosphatases as potential human oncogenes. Science, 269, 1575-1577.
18. Galaktionov, K., Chen, X. and Beach, D. (1996) Cdc25 cell-cycle phosphatase as a target of c-myc. Nature, 382, 511-517.
19. Gasparotto, D., Maestro, R., Piccinin, S., Vukosavljevic, T., Barzan, L., Sulfaro, S. and Boiocchi, M. (1997) Overexpression of CDC25A and CDC25B in head and neck cancers. Cancer Res., 57, 2366-2368.
20. Geley, S., Kramer, E., Gieffers, C., Gannon, J., Peters, J.M. and Hunt, T. (2001) Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint. J. Cell Biol., 153, 137-148.
21. Gong, J., Ardelt, B., Traganos, F. and Darzynkiewicz, Z. (1994) Unscheduled expression of cyclin B1 and cyclin E in several leukemic and solid tumor cell lines. Cancer Res., 54, 4285-4288.
22. Hershko, A. and Ciechanover, A. (1998) The ubiquitin system. Annu. Rev. Biochem., 67, 425-479.
23. Hoffmann, I., Clarke, P.R., Marcote, M.J., Karsenti, E. and Draetta, G. (1993) Phosphorylation and activation of human cdc25-C by cdc2-cyclin B and its involvement in the self-amplification of MPF at mitosis. EMBO J., 12, 53-63.
24. 1/S transition. EMBO J., 13, 4302-4310.
25. Hunter, T. and Pines, J. (1994) Cyclins and cancer, II: cyclin D and CDK inhibitors come of age. Cell, 79, 573-582.
26. Izumi, T., Walker, D.H. and Maller, J.L. (1992) Periodic changes in phosphorylation of the Xenopus cdc25 phosphatase regulate its activity. Mol. Biol. Cell, 3, 927-939.
27. Jinno, S., Suto, K., Nagata, A., Igarashi, M., Kanaoka, Y., Nojima, H. and Okayama, H. (1994) Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J., 13, 1549-1556.
28. Kastan, M.B. (2001) Cell cycle. Checking two steps. Nature, 410, 766-767.
29. 2 checkpoint response in diploid human fibroblasts. Mutat. Res., 400, 153-167.
30. Krek, W., Ewen, M.E., Shirodkar, S., Arany, Z., Kaelin, W.G., Jr and Livingston, D.M. (1994) Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin Adependent protein kinase. Cell, 78, 161-172.
31. Kumagai, A., Yakowec, P.S. and Dunphy, W.G. (1998) 14-3-3 proteins act as negative regulators of the mitotic inducer Cdc25 in Xenopus egg extracts. Mol. Biol. Cell, 9, 345-354.
32. 2/ M phase transition in human cells. J. Cell Sci., 111, 2445-2453.
33. Lew, D.J. and Kornbluth, S. (1996) Regulatory roles of cyclin dependent kinase phosphorylation in cell cycle control. Curr. Opin. Cell Biol., 8, 795-804.
34. 1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol., 15, 2600-2611.
35. Lukas, J., Herzinger, T., Hansen, K., Moroni, M.C., Resnitzky, D., Helin, K., Reed, S.I. and Bartek, J. (1997) Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev., 11, 1479-1492.
36. 1 arrest: Molecular mechanisms and implications for oncogenesis. Oncogene, 18, 3930-3935.
37. Mailand, N., Falck, J., Lukas, C., Syljuasen, R.G., Welcker, M., Bartek, J. and Lukas, J. (2000) Rapid destruction of human Cdc25A in response to DNA damage. Science, 288, 1425-1429.
38. Mailand, N., Lukas, C., Kaiser, B.K., Jackson, P.K., Bartek, J. and Lukas, J. (2002) Deregulated human Cdc14A phosphatase disrupts centrosome separation and chromosome segregation. Nat. Cell Biol., 4, 318-322.
39. Meijer, L., Borgne, A., Mulner, O., Chong, J.P., Blow, J.J., Inagaki, N., Inagaki, M., Delcros, J.G. and Moulinoux, J.P. (1997) Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem., 243, 527-536.
40. Molinari, M., Mercurio, C., Dominguez, J., Goubin, F. and Draetta, G.F. (2000) Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis. EMBO Rep., 1, 71-79.
41. Morgan, D.O. (1995) Principles of CDK regulation. Nature, 374, 131-134.
42. + gene occurs in humans and is highly expressed in some cancer cells. New Biol., 3, 959-968.
43. Nigg, E.A. (1995) Cyclin-dependent protein kinases: Key regulators of the eukaryotic cell cycle. BioEssays, 17, 471-480.
44. Nigg, E.A. (2001) Mitotic kinases as regulators of cell division and its checkpoints. Nat. Rev. Mol. Cell. Biol., 2, 21-32.
45. Nilsson, I. and Hoffmann, I. (2000) Cell cycle regulation by the Cdc25 phosphatase family. Prog. Cell Cycle Res., 4, 107-114.
46. Nurse, P., Masui, Y. and Hartwell, L. (1998) Understanding the cell cycle. Nat. Med., 4, 1103-1106.
47. 2 checkpoint control: Regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science, 277, 1501-1505.
48. 2. Proc. Natl. Acad. Sci. USA, 87, 5139-5143.
49. 1/S-promoting mechanism parallel to the pRb/E2F pathway. Mol. Cell. Biol., 20, 3497-3509.
50. Sarkaria, J.N., Busby, E.C., Tibbetts, R.S., Roos, P., Taya, Y., Karnitz, L.M. and Abraham, R.T. (1999) Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res., 59, 4375-4382.
51. Sexl, V., Diehl, J.A., Sherr, C.J., Ashmun, R., Beach, D. and Roussel, M.F. (1999) A rate limiting function of cdc25A for S phase entry inversely correlates with tyrosine dephosphorylation of Cdk2. Oncogene, 18, 573-582.
52. Shevchenko, A., Jensen, O.N., Podtelejnikov, A.V., Sagliocco, F., Wilm, M., Vorm, O., Mortensen, P., Boucherie, H. and Mann, M. (1996) Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels. Proc. Natl. Acad. Sci. USA, 93, 14440-14445.
53. Shevchenko, A., Chernushevich, I., Ens, W., Standing, K.G., Thomson, B., Wilm, M. and Mann, M. (1997) Rapid 'de novo' peptide sequencing by a combination of nanoelectrospray, isotopic labeling and a quadrupole/time-of-flight mass spectrometer. Rapid Commun. Mass Spectrom., 11, 1015-1024.
54. cdc2 on sites phosphorylated at mitosis. J. Biol. Chem., 269, 5989-6000.
55. Treier, M., Staszewski, L.M. and Bohmann, D. (1994) Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell, 78, 787-798.
56. Vigo, E., Muller, H., Prosperini, E., Hateboer, G., Cartwright, P., Moroni, M.C. and Helin, K. (1999) CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase. Mol. Cell. Biol., 19, 6379-6395.
57. Wilm, M. and Mann, M. (1996) Analytical properties of the nanoelectrospray ion source. Anal. Chem., 68, 1-8.
58. Wu, W., Fan, Y.H., Kemp, B.L., Walsh, G. and Mao, L. (1998) Overexpression of cdc25A and cdc25B is frequent in primary nonsmall cell lung cancer but is not associated with overexpression of c-myc. Cancer Res., 58, 4082-4085.
59. 2-phase checkpoints after ionizing irradiation. Mol. Cell. Biol., 21, 3445-3450.
60. Zhou, B.B. and Elledge, S.J. (2000) The DNA damage response: Putting checkpoints in perspective. Nature, 408, 433-439.